- 期刊
- OpenAccess
Hypertrophic Cardiomyopathy: A Review
並列摘要
Hypertrophic cardiomyopathy (HCM) is a global disease with cases reported in all continents, affecting people of both genders and of various racial and ethnic origins. Widely accepted as a monogenic disease caused by a mutation in 1 of 13 or more sarcomeric genes, HCM can present catastrophically with sudden cardiac death (SCD) or ventricular arrhythmias or insidiously with symptoms of heart failure. Given the velocity of progress in both the fields of heart failure and HCM, we present a review of the approach to patients with HCM, with particular attention to those with HCM and the clinical syndrome of heart failure.
延伸閱讀
- 蘇柏學、李文煌、趙庭興（2023）。The Latest Diagnosis and Treatment of Hypertrophy Cardiomyopathy。內科學誌，34(2)，61-71。https://doi.org/10.6314/JIMT.202304_34(2).01
- Twomley, K. M., & Wells, G. L. (2010). Peripartum Cardiomyopathy: A Current Review. Journal of Pregnancy, 2010(), 13-17. https://doi.org/10.1155/2010/149127
- 莊俊斌、葉東峰、廖朝崧（2000）。Hypertrophic Cardiomyopathy。當代醫學，(316)，139-141。https://doi.org/10.29941/MT.200002.0016
- Peng, T. C., & Chuah, E. C. (2001). Peripartum Cardiomyopathy-A Case Report. Acta Anaesthesiologica Sinica, 39(1), 47-51. https://doi.org/10.6955/AAS.200103.0047
- Bejar, D., Colombo, P. C., Latif, F., & Yuzefpolskaya, M. (2015). Infiltrative Cardiomyopathies. Clinical Medicine Insights: Cardiology, 2015(S2), 29-38. https://doi.org/10.4137/CMC.S19706